Membrane Oxygenators Market Size & Growth Forecast 2027–2036, By Segments (End Use, Type, Age Group, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Membrane Oxygenators Market size was worth USD 136.53 million in 2026 and is expected to grow at a 2.59% CAGR between 2027 and 2036, reaching USD 176.31 million by 2036. The industry revenue for 2027 is assessed at USD 139.48 million.
Get more details on this report
Request Free Sample ReportMembrane Oxygenators Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through advanced cardiac care infrastructure, specialized cardiovascular centers, established extracorporeal life-support capabilities, and continued adoption of sophisticated oxygenation systems in surgical and critical-care applications.
- Asia Pacific is the fastest-growing region, driven by healthcare infrastructure expansion, increasing access to cardiac surgery, rising cardiovascular disease burden, and greater investment in specialized hospitals and critical-care technologies.
Segment Momentum
- Hospitals accounted for 46.53% of the market in 2026, supported by their extensive cardiovascular surgical and critical-care activities. Membrane oxygenators provide essential gas exchange during procedures requiring extracorporeal circulatory support.
- Hollow fiber membrane oxygenators are the largest and fastest-growing type segment because their efficient gas exchange, established clinical use, and continued improvements in biocompatibility support reliable performance in cardiopulmonary bypass and extracorporeal procedures.
Market Expansion Drivers
- Increasing cardiac surgeries and ECMO procedures globally.
- Advancements in oxygenator membrane technology improving efficiency.
- Long-term adoption in emerging markets and hospital expansion programs.
Leading Market Participants
- Major companies in the membrane oxygenators market include Getinge (Sweden), Medtronic (Ireland), LivaNova (UK), Terumo (Japan), Eurosets (Italy), Xenios (Germany), Senko Medical (Japan), Nipro (Japan), Edwards Lifesciences (USA), Fresenius Medical Care (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 136.53 million
- 2027 Estimated Market Size: USD 139.48 million
- Projected Market Size: USD 176.31 million by 2036
- Growth Forecast: 2.59% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: End Use (Hospitals) | Type (Hollow Fiber Membrane Oxygenators) | Age Group (Adults) | Application (Respiratory)
- Emerging Opportunity Segment: End Use (Hospitals) | Type (Hollow Fiber Membrane Oxygenators) | Age Group (Adults) | Application (Cardiac)
Market Growth Drivers and Industry Trends
Increasing Cardiac Surgeries and ECMO Procedures Globally
The rising demand for cardiac surgeries and extracorporeal membrane oxygenation procedures is supporting the adoption of membrane oxygenators in hospitals and specialized medical facilities. These devices provide essential gas exchange by supplying oxygen to blood and removing carbon dioxide during procedures where temporary support of heart and lung function is required. Increasing prevalence of cardiovascular conditions, greater availability of advanced critical care services, and broader use of extracorporeal support are contributing to market growth.
Advancements in Oxygenator Membrane Technology Improving Efficiency
Advancements in membrane materials, oxygenator design, and blood flow management are improving the efficiency and reliability of membrane oxygenation systems. Modern membrane technologies are designed to facilitate effective gas exchange while supporting controlled blood flow and reducing complications associated with prolonged extracorporeal circulation. Continuous innovation aimed at improving biocompatibility, durability, and ease of clinical use is encouraging adoption across cardiac surgery and critical care applications.
Long-Term Adoption in Emerging Markets and Hospital Expansion Programs
Expansion of healthcare infrastructure in emerging markets is creating new opportunities for membrane oxygenators as hospitals develop more advanced cardiac surgery and critical care capabilities. Investments in specialized medical facilities, intensive care capacity, and extracorporeal treatment services are improving access to complex procedures that require oxygenation support. Increasing healthcare awareness and the gradual development of specialized clinical expertise are expected to support sustained adoption of membrane oxygenators in these regions.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing cardiac surgeries and ECMO procedures globally | 0.9% | Short term (≤ 2 yrs) | North America; Europe; Spillover: Asia Pacific | Medium | Fast |
| Advancements in oxygenator membrane technology improving efficiency | 0.8% | Medium term (2–5 yrs) | Europe; North America; Spillover: Asia Pacific | Medium | Moderate |
| Long-term adoption in emerging markets and hospital expansion programs | 0.6% | Long term (5+ yrs) | Asia Pacific; Latin America; Spillover: Europe | Medium | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America held the largest share of the membrane oxygenators market in 2026, led by advanced cardiac care infrastructure, established extracorporeal life support capabilities, and widespread availability of specialized cardiovascular treatment centers. The region has a well-developed network of hospitals equipped to perform complex cardiac and cardiopulmonary procedures requiring extracorporeal circulation, creating sustained demand for membrane oxygenators. Growing adoption of advanced cardiac surgery techniques and increasing utilization of extracorporeal support in critical care are further contributing to market development. Strong clinical expertise, established healthcare systems, and continued investments in medical technology also support the adoption of advanced oxygenation systems designed to provide effective gas exchange during surgical and critical-care applications. In addition, increasing attention to patient outcomes and improvements in extracorporeal support technologies are encouraging healthcare providers to adopt sophisticated membrane oxygenator systems.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to be the fastest-growing region in the membrane oxygenators market, influenced by expanding healthcare infrastructure, increasing access to cardiac surgery, and the growing burden of cardiovascular diseases. Investments in hospitals and specialized cardiovascular centers are improving the availability of advanced surgical and critical-care services across emerging economies. Greater awareness of cardiovascular treatment options and improvements in diagnostic capabilities are also increasing the number of patients receiving interventions that require extracorporeal circulation. At the same time, healthcare systems are progressively adopting advanced life-support technologies as specialist capabilities expand and clinical infrastructure improves. The development of medical facilities in urban and semi-urban areas, together with increasing healthcare expenditure and efforts to strengthen critical-care capacity, is expected to support wider utilization of membrane oxygenators across cardiac surgery and extracorporeal life-support applications.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Advanced Cardiac SupportThe U.S. market emphasizes membrane oxygenators within sophisticated extracorporeal circulation and cardiopulmonary support procedures. Hospitals and device providers prioritize dependable oxygenation, efficient gas exchange, and operational consistency, creating commercial relevance for systems that integrate effectively into complex clinical workflows and advanced perfusion practices.
Germany 🇩🇪
Clinical Device PrecisionGermany’s membrane oxygenators market is supported by established cardiac-care and medical-device capabilities, with purchasing priorities centered on dependable clinical performance and procedural efficiency. Suppliers can strengthen positioning through oxygenators designed for consistent gas exchange, practical integration with extracorporeal circuits, and demanding hospital operating environments.
Japan 🇯🇵
Procedure Reliability FocusJapan’s market places strong importance on reliable membrane oxygenation technologies for cardiac and extracorporeal procedures. Product development and procurement priorities favor compact, dependable systems that support controlled clinical operation, straightforward circuit integration, and consistent performance across procedures requiring cardiopulmonary support.
South Korea 🇰🇷
Modern Perfusion PlatformsSouth Korea’s membrane oxygenators market is connected to modernization of advanced cardiac and extracorporeal treatment capabilities. Commercial opportunities center on oxygenators that combine efficient gas transfer with practical circuit integration, supporting hospitals seeking dependable systems for increasingly sophisticated perfusion and cardiopulmonary procedures.
France 🇫🇷
Cardiac Care IntegrationFrance provides a clinically oriented market for membrane oxygenators, with demand shaped by their role in cardiopulmonary bypass and extracorporeal support. Suppliers can focus on reliable oxygenation, ease of integration into established perfusion workflows, and device characteristics that support consistent operation during complex cardiac procedures.
Italy 🇮🇹
Specialized Perfusion DemandItaly’s membrane oxygenators market is supported by established use in cardiac surgery and extracorporeal circulation. Procurement considerations can favor dependable gas-exchange performance and compatibility with clinical workflows, while suppliers have scope to differentiate through practical device design and reliable operation during specialized perfusion procedures.
Membrane Oxygenators Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
The hospitals segment accounted for the largest share of the membrane oxygenators market at 46.53% share in 2026 and is also expected to be the fastest-growing end-use segment, supported by the widespread use of membrane oxygenators in complex cardiovascular and cardiopulmonary procedures. These devices play an important role in extracorporeal circulation by facilitating oxygen exchange and carbon dioxide removal when the patient’s natural cardiopulmonary function must be temporarily supported. Hospitals perform a broad range of cardiac surgeries and other procedures requiring extracorporeal support, creating consistent demand for reliable oxygenation technologies. Increasing surgical volumes, improvements in cardiac care, and the expansion of specialized hospital facilities are contributing to the need for advanced oxygenator systems. Technological improvements are also enhancing gas-transfer efficiency, biocompatibility, blood handling, and overall device performance, supporting their use in increasingly complex procedures. As hospitals continue to strengthen cardiovascular and critical-care capabilities, the need for dependable extracorporeal oxygenation solutions is expected to sustain demand and reinforce hospitals as a key end-use segment.
Type Segment Analysis: Hollow Fiber Membrane Oxygenators (Largest & Fastest-Growing Segment)
The hollow fiber membrane oxygenators segment represents the largest share in the membrane oxygenators market and is also expected to be the fastest-growing type segment in 2026, supported by the efficient gas-exchange capabilities and established clinical use of hollow fiber technology. These oxygenators use bundles of fine hollow fibers that provide a large surface area for oxygen and carbon dioxide exchange while maintaining separation between blood and gas pathways. Their design enables effective oxygenation with controlled blood flow and supports use in a wide range of cardiopulmonary bypass and extracorporeal procedures. Continued improvements in membrane materials, fiber configurations, coatings, and device design are enhancing biocompatibility and reducing complications associated with blood contact. Healthcare providers also benefit from the established familiarity and procedural compatibility of hollow fiber systems, supporting their broad adoption. As cardiovascular procedures and extracorporeal support applications expand, ongoing demand for efficient, reliable, and biocompatible oxygenation technology is expected to maintain the segment’s leading position and support further growth.
Age Group Segment Analysis: Adults (Largest & Fastest-Growing Segment)
The adults segment represents the largest share in the membrane oxygenators market in 2026 and is also expected to be the fastest-growing age group segment, reflecting the extensive use of extracorporeal oxygenation technologies in adult cardiovascular and critical-care procedures. Adult patients account for a broad range of cardiac surgeries and interventions in which cardiopulmonary bypass and temporary extracorporeal support are required, generating sustained demand for appropriately designed membrane oxygenators. The increasing prevalence of cardiovascular conditions and the continued development of specialized cardiac treatment programs are supporting procedural demand among adult patients. Advances in surgical techniques and perioperative care are also enabling healthcare providers to manage increasingly complex cases, further reinforcing the need for reliable oxygenation systems. In addition, improvements in oxygenator design, blood compatibility, and gas-transfer performance are enhancing device suitability for adult procedures. Continued investment in cardiovascular care infrastructure and the growing need for advanced surgical and extracorporeal support are expected to sustain the strong role of adult applications in the age group segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Hospitals |
| Type | Hollow Fiber Membrane Oxygenators, Flat Sheet Membrane Oxygenators | Hollow Fiber Membrane Oxygenators | Hollow Fiber Membrane Oxygenators |
| Age Group | Adults, Neonates, Pediatrics | Adults | Adults |
| Application | Respiratory, Cardiac, Extra Corporeal Cardiopulmonary Resuscitation | Respiratory | Cardiac |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Value creation in the membrane oxygenator market is driven by balancing acute gas exchange performance with long-term biological safety. Leading manufacturers prioritize gas transfer efficiency for oxygen uptake and carbon dioxide clearance while maintaining low flow resistance across various clinical operating ranges. To minimize patient complications during prolonged cardiopulmonary support, devices rely on advanced materials and surface coatings that improve hemocompatibility and mitigate thrombogenicity. Stability during extended-duration ECMO support serves as a core competitive metric, as consistent circuit pressure and reliable gas exchange outweigh short-term efficiency claims. Additionally, compact internal pathways that yield low priming volumes are increasingly critical, particularly in pediatric applications where minimizing hemodilution directly enhances clinical usability.
Major players in the membrane oxygenators market:
- Getinge (Sweden)
- Medtronic (Ireland)
- LivaNova (UK)
- Terumo (Japan)
- Eurosets (Italy)
- Xenios (Germany)
- Senko Medical (Japan)
- Nipro (Japan)
- Edwards Lifesciences (USA)
- Fresenius Medical Care (Germany)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Getinge (Sweden) | |||||||
| Medtronic (Ireland) | |||||||
| LivaNova (UK) | |||||||
| Terumo (Japan) | |||||||
| Eurosets (Italy) | |||||||
| Xenios (Germany) | |||||||
| Senko Medical (Japan) | |||||||
| Nipro (Japan) | |||||||
| Edwards Lifesciences (USA) | |||||||
| Fresenius Medical Care (Germany) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Inspira Technologies | May 2023 | Inspira Technologies announced the development of the VORTX Blood Oxygenator, an advanced technology designed to optimize oxygen saturation and carbon dioxide removal in blood. The development targets critical-care applications and represents an expansion of oxygenation technology aimed at supporting improved patient outcomes. |
| Getinge | February 2022 | Getinge acquired U.S.-based Talis Clinical, a provider of high-acuity IT software applications for critical care, including extracorporeal membrane oxygenation (ECMO). The acquisition strengthens Getinge’s ECMO and perfusion digital solutions portfolio by adding Talis Clinical’s critical-care software capabilities to its existing offering. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Membrane Oxygenators Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Procurement Model | Direct hospital procurement, Group purchasing organization procurement, Distributor procurement |
| Oxygenator Lifecycle | Single-use oxygenators, Extended-use oxygenators |
| Anticoagulation Approach | Heparin-coated systems, Non-heparin-coated systems |
Membrane Oxygenators Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Extracorporeal Life Support Adoption Pathways |
|
| Hospital Procurement & Vendor Selection Dynamics |
|
| Disposable Medical Device Supply Resilience |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the overall size of the membrane oxygenators market?
How is the membrane oxygenators industry expected to grow over the next 10 years?
How is the expansion of cardiac surgery and extracorporeal care driving membrane oxygenator demand?
How is healthcare infrastructure expansion creating new membrane oxygenator opportunities in emerging markets?
Why do hospitals dominate the membrane oxygenators market?
What is driving demand for hollow fiber membrane oxygenators?
Why does North America lead the membrane oxygenators market?
How is Asia Pacific creating new opportunities in the membrane oxygenators market?
What are the prominent companies operating in the membrane oxygenators landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook